EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serofast Syphilis Is Associated with Phospholipid-Dependent Coagulation Abnormalities and B-Cell Activation Following Treatment

Martyna Kiolbasa iD, Konrad Kaminiow iD, Damian Kadylak, Maciej Pastuszczak

International Journal of Molecular Sciences · 29.05.2026 · 27 (11) · 4954

DOI: 10.3390/ijms27114954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.05.2026. Verfasst von Martyna Kiolbasa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Dermatology, Medical University of Silesia, 41-800 Zabrze, Poland. Hauptthemen laut MEDLINE: Syphilis, Lymphocyte Activation, B-Lymphocytes, Phospholipids. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A substantial proportion of patients treated for early syphilis fail to achieve the expected ≥4-fold decline in non-treponemal titers despite appropriate therapy. This serofast state remains a common clinical dilemma, and repeated antibiotic therapy is often ineffective. We hypothesized that persistent seroreactivity may reflect infection-associated immune dysregulation rather than ongoing infection. In this prospective study, 36 adults with early syphilis were treated with benzathine penicillin. At 6 months, 11 patients with inadequate serological response underwent cerebrospinal fluid evaluation; 3 with neurosyphilis were excluded. The remaining 33 patients were classified as serofast (n = 8) or serologically cured (n = 25). Eleven healthy individuals served as controls. Serofast patients demonstrated prolonged phospholipid-dependent coagulation assays compared with serologically cured individuals (all qBH < 0.01; δ = 0.75–0.83). They also exhibited higher BAFF levels and B-cell counts at baseline and follow-up. Posttreatment VDRL titers strongly correlated with BAFF levels, B-cell counts, and coagulation parameters. After exclusion of neurosyphilis, persistent non-treponemal seroreactivity was associated with coordinated B-cell activation and phospholipid-dependent coagulation abnormalities, suggesting an infection-triggered immune phenotype rather than ongoing Treponema pallidum infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SyphilisLymphocyte ActivationB-LymphocytesPhospholipidsBlood Coagulation DisordersHumansAdultFemaleMaleMiddle AgedAnti-Bacterial AgentsPenicillin G BenzathineBlood CoagulationB-Cell Activating FactorSyphilis SerodiagnosisTreponema pallidumProspective StudiesCardiolipinsCholesterolPhosphatidylcholines

Stichwörter der Autor:innen

VDRLautoimmunitycoagulationserofastsyphilis

Substanzen

PhospholipidsAnti-Bacterial AgentsPenicillin G BenzathineB-Cell Activating FactorVDRL antigenCardiolipinsCholesterolPhosphatidylcholines

Autor:innen und Institutionen

  • Clinical Department of Dermatology, Medical University of Silesia, 41-800 Zabrze, Poland.
  • Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland.

ORCID-Profile: Martyna Kiolbasa, Konrad Kaminiow

Zitieren

APA

Kiolbasa, M., Kaminiow, K., Kadylak, D., & Pastuszczak, M. (2026). Serofast Syphilis Is Associated with Phospholipid-Dependent Coagulation Abnormalities and B-Cell Activation Following Treatment. International Journal of Molecular Sciences, 27(11), 4954. https://doi.org/10.3390/ijms27114954

Vancouver

Kiolbasa M, Kaminiow K, Kadylak D, Pastuszczak M. Serofast Syphilis Is Associated with Phospholipid-Dependent Coagulation Abnormalities and B-Cell Activation Following Treatment. International Journal of Molecular Sciences. 2026;27(11):4954. doi:10.3390/ijms27114954

BibTeX
@article{Kiolbasa2026,
  author = {Kiolbasa, Martyna and Kaminiow, Konrad and Kadylak, Damian and Pastuszczak, Maciej},
  title = {Serofast Syphilis Is Associated with Phospholipid-Dependent Coagulation Abnormalities and B-Cell Activation Following Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {4954},
  doi = {10.3390/ijms27114954}
}
Kostenlos starten →